Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
23/05/202421:30Business WireKao veröffentlicht Fortschrittsbericht über seine ESG-Strategie – Der Kirei Lifestyle Plan
23/05/202421:30Business WireKao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan
23/05/202421:18Business WireiStaging reveals Next Generation MR experiences at VivaTech 2024.
23/05/202421:10Business WireMitsubishi Electric to Establish Vietnamese JV for FA Products
23/05/202421:00NEWSBTCBitcoin’s Network Strengthens: Mining Difficulty And Hash Rate Spike Amid ETH ETF BuzzCOIN:ETHUSDEthereum
23/05/202421:00GlobeNewswire Inc.Fairfax Announces the Passing of Ramaswamy AthappanTSX:FFH.UFairfax Financial Holdings Limited
23/05/202420:58NEWSBTCEthereum Price Dips, Then Rips: Exciting Trading Opportunities AheadCOIN:ETHUSDEthereum
23/05/202420:55PR Newswire (US)Azul and GOL Announce Codeshare AgreementNYSE:AZULAzul SA
23/05/202420:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
23/05/202420:52PR Newswire (Canada)Rappel du gobelet NÜTRL de la marque Sunscope au Canada
23/05/202420:50Business Wireセルトリオン、欧州委員会からオマリズマブ バイオシミラー「Omlyclo®(CT-P39)」の承認を取得 – 欧州初・唯一の承認
23/05/202420:49GlobeNewswire Inc.Imperial Announces Voting Results for the Election of DirectorsTSX:IIIImperial Metals Corporation
23/05/202420:49Business WireCelltrion riceve l'approvazione della Commissione europea per Omlyclo® (CT-P39), il primo e unico farmaco biosimilare di omalizumab approvato in Europa
23/05/202420:48PR Newswire (US)LENNAR DFW DIVISION HOSTS HOPEKIDS EVENT FOR CHILDREN WITH LIFE-THREATENING MEDICAL CONDITIONS AT KIDZANIA USA
23/05/202420:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
23/05/202420:44PR Newswire (Canada)Sunscope Recalls NÜTRL-Branded Tumbler Cup in Canada
23/05/202420:43PR Newswire (US)What made ASML so successful today: DIGITIMES Asia's Q&A with Dutch Journalist and author Marc Hijink
23/05/202420:42Business WireThe World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
23/05/202420:37GlobeNewswire Inc.Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
23/05/202420:31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INSEInspired Entertainment Inc
23/05/202420:31PR Newswire (US)IEHP's newly announced Community Wellness Center adds more heart to the city of San Bernardino
23/05/202420:26Business WireCelltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
23/05/202420:23NEWSBTCBitcoin Price Dips Again: Market Fluctuation or Start of a Correction?COIN:BTCUSDBitcoin
23/05/202420:21PR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc
23/05/202420:20PR Newswire (Canada)TSX Venture Exchange Stock Maintenance Bulletins
23/05/202420:19GlobeNewswire Inc.ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des JahresEU:ONWDOnward Medical NV
23/05/202420:19GlobeNewswire Inc.ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écouléeEU:ONWDOnward Medical NV
23/05/202420:15PR Newswire (US)ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
23/05/202420:03GlobeNewswire Inc.Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024NASDAQ:ANLAdlai Nortye Ltd
23/05/202420:02PR Newswire (US)Heart to Heart Hospice of San Antonio Opens New Hospice House